Vericel Corp Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Vericel Corporation on May 18, 2026. The report addresses a corporate governance update regarding the Company's principal executive offices.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report does not contain financial statements or performance metrics.
Material Changes
Effective May 18, 2026, the Board of Directors approved an amendment to the Company's bylaws. This amendment reflects the relocation of the Company's principal executive offices to a new global headquarters at 25 Blue Sky Drive, Burlington, Massachusetts 01803.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document is limited to the administrative update of the bylaws and the address change.
Key Facts for Investors
- Vericel Corporation has moved its global headquarters to Burlington, Massachusetts.
- The Company's bylaws were amended effective May 18, 2026, to reflect the new address.
- The full text of the Second Amended and Restated Bylaws is available as Exhibit 3.1.
- No financial data or operational results are disclosed in this specific filing.